Skip to main content

Filtration of Traffic-Related Air Pollution Mitigates Its Impact on BP

Medically reviewed by Carmen Pope, BPharm. Last updated on Nov 28, 2023.

By Elana Gotkine HealthDay Reporter

MONDAY, Nov. 27, 2023 -- Filtration of traffic-related air pollution (TRAP) may mitigate its adverse effects on blood pressure, according to a study published online Nov. 28 in the Annals of Internal Medicine.

Michael T. Young, M.P.H., Ph.D., from the University of Washington in Seattle, and colleagues conducted a randomized crossover trial involving in-vehicle scripted commutes driven through traffic in Seattle among 16 normotensive persons aged 22 to 45 years (mean age, 29.7 years). On-road air was entrained into the vehicle on two days; the vehicle was equipped with high-efficiency particulate air (HEPA) filtration on another day. Before, during, and up to 24 hours after a drive, 14 three-minute periods of blood pressure were recorded.

Predrive blood pressure was 122.7/70.8 mm Hg; drive duration was 122.3 minutes. The researchers found that among 13 participants with complete data, mean diastolic blood pressure at one hour was 4.7 mm Hg higher for unfiltered drives versus filtered drives, adjusting for predrive levels, order, and carryover; mean adjusted systolic blood pressure was 4.5 mm Hg higher. At 24 hours, adjusted mean diastolic and systolic blood pressure were 3.8 and 1.1 mm Hg higher, respectively, for unfiltered drives. In unfiltered drives, the adjusted mean image-based central retinal arteriolar equivalent was 2.7 µm wider.

"Our study reinforces existing literature suggesting that traffic-derived particulate matter may be implicated in hypertension," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

HTN, Albuminuria Risks No Worse for Kidney Donors Versus Nondonors

THURSDAY, May 30, 2024 -- Living kidney donors and nondonors have similar risks for hypertension and albuminuria, according to a study published online May 23 in the Journal of...

Antihypertensives Linked to Eczematous Dermatitis in Seniors

FRIDAY, May 24, 2024 -- Antihypertensive drugs are associated with an increased risk for eczematous dermatitis in older adults, and the effect sizes are largest for diuretics and...

Social Determinants of Health Explain Disparities in Treatment-Resistant Hypertension

TUESDAY, May 21, 2024 -- Part of the association between race and incident apparent treatmentā€resistant hypertension (aTRH) risk is mediated by social determinants of health, a...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.